← Browse by Condition
Medical Condition
tnbc triple negative breast cancer
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 1
NCT06125080 Phase 2
Recruiting
The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study
Enrollment
78 pts
Location
China
Sponsor
Huihua Xiong
NCT06568692 Phase 2
Recruiting
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Enrollment
90 pts
Location
United States
Sponsor
Processa Pharmaceuticals
NCT05768932 Phase 1
Recruiting
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Enrollment
260 pts
Location
United States, South...
Sponsor
SillaJen, Inc.
NCT07327489
Recruiting
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Enrollment
2,000 pts
Location
United States
Sponsor
Elephas
NCT06682195 Phase 2
Recruiting
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
Enrollment
35 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
NCT06387628 Phase 2
Recruiting
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
Enrollment
74 pts
Location
China
Sponsor
Fudan University